These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 13804624)

  • 1. Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain.
    BRODIE BB; SPECTOR S; SHORE PA
    Ann N Y Acad Sci; 1959 Sep; 80():609-16. PubMed ID: 13804624
    [No Abstract]   [Full Text] [Related]  

  • 2. Some relationships between peripheral monoamine oxidase inhibition and brain 5-hydroxytryptamine levels in rats.
    TABACHNICK II; RUBIN AA
    Proc Soc Exp Biol Med; 1959 Jul; 101(3):435-7. PubMed ID: 13675270
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhibition "in vitro" of monoamine oxidase].
    NARANJO R
    Rev Asoc Medica Mex; 1960 Jun; 40():272-9. PubMed ID: 14426018
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on the active center of monoamine oxidase.
    ZELLER EA
    Experientia; 1960 Sep; 16():399-402. PubMed ID: 13788171
    [No Abstract]   [Full Text] [Related]  

  • 5. Antagonism between harmaline and longacting monoamine oxidase inhibitors concerning the effect on 5-hydroxytryptamine and norepinephrine metabolism in the brain.
    PLETSCHER A; BESENDORF H
    Experientia; 1959 Jan; 15(1):25-6. PubMed ID: 13619675
    [No Abstract]   [Full Text] [Related]  

  • 6. The route of administration of some hydrazine compounds as a determinant of brain and liver monoamine oxidase inhibition.
    HORITA A
    Toxicol Appl Pharmacol; 1961 Jul; 3():474-80. PubMed ID: 13715854
    [No Abstract]   [Full Text] [Related]  

  • 7. Accumulation of serotonin in the brain of reserpine-treated mice after inhibition of monoamine oxidase: effect of body temperature.
    DUBNICK B; LEESON GA; CHESSIN M; SCOTT CC
    Arch Int Pharmacodyn Ther; 1960 Jun; 126():194-202. PubMed ID: 13818306
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative effects of monoamine oxidase inhibitors on monoamine oxidase and diamine oxidase.
    SHORE PA; COHN VH
    Biochem Pharmacol; 1960 Oct; 5():91-5. PubMed ID: 13912256
    [No Abstract]   [Full Text] [Related]  

  • 9. Some remarks about monoamine oxidase and monoamine oxidase inhibitors.
    ZELLER EA
    J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():125-30. PubMed ID: 13788170
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent biochemical developments with monoamine oxidase inhibitors.
    SHORE PA
    Dis Nerv Syst; 1960 Mar; 21(3)Suppl():62-3. PubMed ID: 14446179
    [No Abstract]   [Full Text] [Related]  

  • 11. [Monoamine liberators and monoamine oxidase inhibitors].
    LEUSEN I
    Psychiatr Neurol (Basel); 1960 Jul; 140():154-64. PubMed ID: 13761295
    [No Abstract]   [Full Text] [Related]  

  • 12. The interaction between reversible and irreversible monoamine oxidase inhibitors.
    HORITA A; McGRATH WR
    Biochem Pharmacol; 1960 Jun; 3():206-11. PubMed ID: 14403109
    [No Abstract]   [Full Text] [Related]  

  • 13. Species differences in the action of monoamine oxidase inhibitors.
    PLETSCHER A; GOSCHKE H; GEY KF; THOLEN H
    Med Exp Int J Exp Med; 1961; 4():113-7. PubMed ID: 13736341
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with monoamine oxidase inhibitors and other substances controlling serotonin metabolism].
    CONSBRUCH U; FAUST C
    Psychiatr Neurol (Basel); 1960 Jul; 140():76-82. PubMed ID: 13695106
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
    WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
    J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoamine oxidase inhibition.
    ROSENBLUM I; FERGUSON FC
    Clin Pharmacol Ther; 1960; 1():692-3. PubMed ID: 13743428
    [No Abstract]   [Full Text] [Related]  

  • 17. The distribution of monoamine oxidase and succinic oxidase in brain.
    WEINER N
    Proj Rep USAF Sch Aviat Med; 1960 Jun; 60(65):1-7. PubMed ID: 24545966
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and pharmacological effects of the monoamine oxidase inhibitors, iproniazid, 1-phenyl-2-hydrazinopropane (JB 516) and 1-phenyl-3-hydrazinobutane (JB 835).
    SPECTOR S; SHORE PA; BRODIE BB
    J Pharmacol Exp Ther; 1960 Jan; 128():15-21. PubMed ID: 13833205
    [No Abstract]   [Full Text] [Related]  

  • 19. [Monoamine oxidase inhibitors].
    MACIAS CASTRO I
    Arch Hosp Univ; 1960; 12():330-3. PubMed ID: 13764845
    [No Abstract]   [Full Text] [Related]  

  • 20. MONOAMINE oxidase inhibitors.
    Br Med J; 1959 Dec; 2(5161):1238. PubMed ID: 13856860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.